Intellipharmaceutics International Inc. (IPCI)

[AngeloFoca]

a $3.8 billion brand sales drug

Doog - Those must be old numbers - I would go by IPCI's number of $751 Million yearly sales.

I think they could capture up to 20% of that market or $150 Million...

BUT - I think that since they brought it to approval on their dime... and not partnered it until AFTER approval they CAN/WILL command as much as 50% in royalty payments, or ~ $75 Million

Divide that by 25 million shares and you have $3.00 earnings x p/e of 20 = $60.00 per share just for effexor.

Those #'s are best case scenario - but even being conservative is impressive.

Capture 10% of market or $75 Million year - Get 33% royalty on sales or $25 million, divide by 25 million shares = $1.00 earnings x 10 p/e = $10 per share just for effexor.